Trial Profile
A 52-Week, Multinational, Multi-Centre, Open-Labelled, Randomised, Parallel, Efficacy and Safety Comparison of Insulin Detemir and NPH Insulin in Children and Adolescents 2-16 years with Type 1 Diabetes on a Basal-Bolus Regimen with Insulin Aspart as Bolus Insulin
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Oct 2021
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Insulin aspart; Insulin suspension isophane
- Indications Type 1 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Novo Nordisk
- 24 Oct 2012 Primary endpoint 'Proportion-of-glycosylated-haemoglobin' has been met.
- 29 Jun 2012 Official title amended as reported by European Clinical Trials Database.(Parent trial: EudraCT2006-000051-18).
- 30 Sep 2009 Results presented at the 45th Annual Meeting of the European Association for the Study of Diabetes (EASD).